Good Jennifer L's Form 4 filing
Trevi Therapeutics, Inc. (TRVI) · filed Sep 5, 2024
- Accession no.
- 0000950170-24-104061
- Filed
- Sep 5, 2024
- Trade date
- Sep 3-5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $170.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Good Jennifer LCIK 0001229245 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseAcquired | +3,863 | $1.43 | +$5,524.09 | 217,176 | Direct | |
| Sep 3, 2024 | Common Stock | SSaleDisposed | −3,863 | $3.02 | −$11,666.26 | 213,313 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseAcquired | +10,981 | $1.43 | +$15,702.83 | 224,294 | Direct | |
| Sep 4, 2024 | Common Stock | SSaleDisposed | −10,981 | $3.02 | −$33,162.62 | 213,313 | Direct | |
| Sep 5, 2024 | Common Stock | MOption exerciseAcquired | +40,277 | $1.43 | +$57,596.11 | 253,590 | Direct | |
| Sep 5, 2024 | Common Stock | SSaleDisposed | −40,277 | $3.11 | −$125,261.47 | 213,313 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2024 | Common Stock | MOption exerciseDisposed | −3,863 | $0.00 | $0 | 57,317 | Direct | |
| Sep 4, 2024 | Common Stock | MOption exerciseDisposed | −10,981 | $0.00 | $0 | 46,336 | Direct | |
| Sep 5, 2024 | Common Stock | MOption exerciseDisposed | −40,277 | $0.00 | $0 | 6,059 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.